July 15, 2021 | BALTIMORE – Complete Omics’ Clinical Proteomics team announced a collaboration with Dr. Benjamin Vincent from The University of North Carolina, on neoantigen-related projects.
Dr. Vincent’s research focuses on immunogenomics and systems approaches to understanding cancer immunobiology, with the goal of developing clinically relevant insights and new cancer immunotherapies.
Complete Omics is proud to work with Dr. Vincent and his group to leverage our neoantigen validation platforms for personalized cancer patient care.
